About this trial
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.
Disqualifiers
N/A
Trial population
Any participant having labs drawn as standard of care will have blood drawn for the study if consented/assented. All participants who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank. The principle investigator will be looking at tissue from these participants. There is no further recruitment for the study.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Correlation of Biomarkers with Differential Diagnosis
Correlation of Biomarkers with Disease Severity
Correlation of Biomarkers with Response to Therapies
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Children's Hospital Medical Center, Cincinnati
Lead sponsor
Lymphangiomatosis and Gorham's Disease Alliance (LGDA)
Collaborator
Klippel Trenaunay (KT) Support Group
Collaborator
CLOVES Syndrome Community Support Group
Collaborator